Trial to Evaluate the Efficacy and Safety of HCP1302
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 232 participants.
Also called NCT02587988
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 232 participants
- Registry
-
NCT02587988
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02587988. Randomized; double masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2015-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial to Evaluate the Efficacy and Safety of HCP1302
- Condition
- Erectile Dysfunction
- Condition
- Hypertension
- Intervention (Drug)
- HCP1302
- Intervention (Drug)
- HGP0904
- Intervention (Drug)
- Placebo (for HCP1302)
- Intervention (Drug)
- Placebo (for HGP0904)
- Lead sponsor
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct02587988- Content hash
8e414a46e452c52e3ed78f74a5f3c7d6cba178d9835507a2b90d8625d0fe0f8b